ATRA vs. OKTA
ATRA (Atara Biotherapeutics, Inc.) and OKTA (Okta, Inc.) are both stocks. ATRA operates in Biotechnology (Healthcare), while OKTA operates in Software - Infrastructure (Technology). Over the past 5 years, ATRA returned -51.70%/yr vs -10.55%/yr for OKTA. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
ATRA vs. OKTA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATRA achieves a -53.68% return, which is significantly lower than OKTA's 64.14% return.
ATRA
- 1D
- 2.57%
- 1M
- -28.07%
- 6M
- 61.15%
- YTD
- -53.68%
- 1Y
- -27.45%
- 3Y*
- -46.18%
- 5Y*
- -51.70%
- 10Y*
- -34.79%
- ALL TIME*
- -24.96%
OKTA
- 1D
- 1.08%
- 1M
- 0.36%
- 6M
- 68.00%
- YTD
- 64.14%
- 1Y
- 49.20%
- 3Y*
- 23.04%
- 5Y*
- -10.55%
- 10Y*
- —
- ALL TIME*
- 21.16%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $466.37K | $668.90K | $13.86M | |
OKTA Okta, Inc. | $370.04M | $412.72M | $441.76M |
ATRA vs. OKTA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ATRA Atara Biotherapeutics, Inc. | -53.68% | 35.91% | 3.82% | -84.37% | -79.19% | -19.71% | 19.19% | -52.59% | 91.93% | -2.16% |
OKTA Okta, Inc. | 64.14% | 9.73% | -12.96% | 32.49% | -69.52% | -11.83% | 120.39% | 80.83% | 149.12% | 7.83% |
Correlation
The correlation between ATRA and OKTA is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.09 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Apr 7, 2017 | 0.26 |
The correlation between ATRA and OKTA shifts across timeframes, from 0.09 (1 year) to 0.26 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ATRA:
$75.51M
OKTA:
$23.58B
ATRA:
-$0.70
OKTA:
$0.97
ATRA:
4.98
OKTA:
11.40
ATRA:
$22.62M
OKTA:
$2.23B
ATRA:
$21.73M
OKTA:
$1.73B
ATRA:
-$6.92M
OKTA:
$235.06M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATRA vs. OKTA — Risk / Return Rank
ATRA
OKTA
ATRA vs. OKTA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atara Biotherapeutics, Inc. (ATRA) and Okta, Inc. (OKTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATRA | OKTA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.99 | ||
| Sortino ratioReturn per unit of downside risk | -0.82 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.20 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.36 | 1.27 | -1.63 |
| Martin ratioReturn relative to average drawdown | -0.58 | 3.22 | -3.80 |
Loading charts...
Drawdowns
ATRA vs. OKTA - Drawdown Comparison
The maximum ATRA drawdown since its inception was -99.74%, which is greater than OKTA's maximum drawdown of -84.57%. Use the drawdown chart below to compare losses from any high point for ATRA and OKTA.
Loading charts...
Drawdown Indicators
| ATRA | OKTA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.74% | -84.57% | -15.17% |
Max Drawdown (1Y)Largest decline over 1 year | -76.89% | -35.62% | -41.27% |
Max Drawdown (3Y)Largest decline over 3 years | -92.76% | -50.57% | -42.19% |
Max Drawdown (5Y)Largest decline over 5 years | -99.16% | -83.43% | -15.73% |
Max Drawdown (10Y)Largest decline over 10 years | -99.68% | — | — |
Current DrawdownCurrent decline from peak | -99.48% | -51.36% | -48.12% |
Average DrawdownAverage peak-to-trough decline | -74.31% | -38.48% | -35.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.23% | 14.07% | +33.16% |
Volatility
ATRA vs. OKTA - Volatility Comparison
Atara Biotherapeutics, Inc. (ATRA) has a higher volatility of 21.45% compared to Okta, Inc. (OKTA) at 15.99%. This indicates that ATRA's price experiences larger fluctuations and is considered to be riskier than OKTA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATRA | OKTA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.45% | 15.99% | +5.46% |
Volatility (6M)Calculated over the trailing 6-month period | 92.58% | 50.01% | +42.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 143.69% | 56.94% | +86.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 122.28% | 57.96% | +64.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 100.43% | 53.96% | +46.47% |
Dividends
ATRA vs. OKTA - Dividend Comparison
Neither ATRA nor OKTA has paid dividends to shareholders.
Financials
ATRA vs. OKTA - Financials Comparison
This section allows you to compare key financial metrics between Atara Biotherapeutics, Inc. and Okta, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATRA and OKTA have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATRA has higher volatility (21.45%) compared to OKTA (15.99%). In terms of maximum drawdown, ATRA dropped -99.74% vs OKTA's -84.57%.
OKTA currently has the higher Sharpe Ratio (0.80 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATRA and OKTA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer